What to know about Medicare drug price negotiation

Moving Medicine

A tartalmat a Aly Schweigert and American Medical Association biztosítja. Az összes podcast-tartalmat, beleértve az epizódokat, grafikákat és podcast-leírásokat, közvetlenül a Aly Schweigert and American Medical Association vagy a podcast platform partnere tölti fel és biztosítja. Ha úgy gondolja, hogy valaki az Ön engedélye nélkül használja fel a szerzői joggal védett művét, kövesse az itt leírt folyamatot https://hu.player.fm/legal.

1+ y ago 21:05

MP3•Epizód kép

In this episode, Todd Askew, AMA senior vice president of Advocacy, presents what physicians need to know about Medicare drug price negotiations for seniors in the US health care system. The topic has ebbed and flowed for many years and has recently been debated again in Congress. Allowing CMS to negotiate drug prices on behalf of its beneficiaries and private plan enrollees would help reduce out-of-pocket spending. Listen in to learn more. 📺 Follow the AMA on YouTube: @americanmedicalassociation 🎥 Watch #AMAUpdate for the latest in health care news for physicians: https://bit.ly/AMA_Update 📧 Subscribe to AMA Morning Rounds newsletter, with the news you need every morning delivered to your inbox: https://bit.ly/AMA-MorningRounds 🎧 Listen to our latest podcast episodes now: https://bit.ly/AMA_Podcasts 📲 Download AMA Connect for news, podcasts, video updates and learning in one place: https://apple.co/3URzNES

234 epizódok

#Medicine #Americanmedicalassociation #Fitness #Aly Schweigert #American Medical Association #Patient Privacy #Healthcare #Medical #Burnout #Digital Health #Health and Well-Being #Medical Advocacy #Telehealth #Physicians #Women In Medicine #Health Equity #AMA